EN
HI
Bafna Pharmaceuticals Share Price
BAFNAPH
371.357.20 (1.98%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 1 Oct, 2026, Bafna Pharmaceuticals stock price is ₹371.35. During the trading session, the stock has moved between an intraday low of ₹371.35 and an intraday high of ₹371.40. Over the last 52 weeks, Bafna Pharmaceuticals has traded between ₹94.77 and ₹371.40.
The stock has recorded a trading volume of 546 shares,. Its Average Traded Price (ATP) is ₹371.39, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 16 @ ₹371.35.
Bafna Pharmaceuticals has an upper circuit limit of ₹371.40 and a lower circuit limit of ₹356.90. The total value traded stands at ₹2.03 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Bafna Pharmaceuticals also offers a dividend yield of 0%.
Bafna Pharmaceuticals Share Price Chart
Bafna Pharmaceuticals Share Key Metrics
Volume
546.00
Market Cap
861.45 CR
LTQ@LTP
16@371.35
ATP
371.39
Var Margin
100 %
Circuit Range
356.9-371.4
Delivery %
0 %
Value
2.03 L
ASM/GSM
No
Market Lot
1
Bafna Pharmaceuticals Resistance and Support
Pivot 364.15
Resistance
First Resistance
364.15
Second Resistance
364.15
Third Resistance
364.15
Support
First Support
364.15
Second Support
364.15
Third Support
364.15
Bafna Pharmaceuticals Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
75%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
9.34%
Domestic Institutional Investors
0%
Retail
15.66%
Others
0%
Total Promoters
MAR '26
75%
JUN '26
75%
Bafna Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Bafna Pharmaceuticals Management
| Name | Position |
|---|---|
| Shanmugam Hemalatha | Whole Time Director |
| Vinayak Dinesh Dendukuri | Whole Time Director - Quality |
Bafna Pharmaceuticals FAQs
The Buying Price of Bafna Pharmaceuticals share is 371.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bafna Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bafna Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bafna Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bafna Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bafna Pharmaceuticals’s valuation compare Sector P/E, P/B which are 43.56 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bafna Pharmaceuticals is 861.45 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bafna Pharmaceuticals share price is 371.40 & 94.77. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bafna Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BAFNAPH
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC